CERo Therapeutics Inc. (CERO)

AI Score

Unlock

0.62

0.02 (3.85%)

At close: Apr 17, 2025, 3:59 PM

0.60

-3.28%

After-hours: Apr 17, 2025, 07:55 PM EDT

CERo Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021
PE Ratio	n/a	-27.41	-45.42	-442.86	-6.07K	-5.15K	-1.3K	-3.75K	-6.62K	68.6K	-51.6K	-15.21K	-18.1K	n/a	-1.17M
PEG Ratio	n/a	0.63	7.27	-1.75	432.62	68.71	-6.66	-44.93	5.76	-390.86	735.84	-772	n/a	n/a	n/a
PS Ratio	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
PB Ratio	n/a	-125.18	-179.23	-2.75K	-1.19K	-1.25K	13.43K	3.64K	2.82K	136.06	135.18	134.96	133.32	n/a	194.21K
P/FCF Ratio	n/a	-351.57	-125.75	-801.92	-36.82K	-26.85K	-3.56K	-5.03K	-18.63K	-133K	-97.28K	-74.67K	-32.67K	n/a	n/a
P/OCF Ratio	n/a	-351.57	-125.75	-801.92	-36.82K	-26.85K	-3.56K	-5.03K	-18.63K	-133K	-97.28K	-74.67K	-32.67K	n/a	n/a
OCF/S Ratio	3.57	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Debt / Equity Ratio	-0.83	-0.49	-0.87	-1.73	-0.27	-0.25	2.14	0.33	0.26	n/a	n/a	n/a	n/a	n/a	n/a
Quick Ratio	0.50	0.39	0.48	0.47	1.65	1.76	3.20	0.12	1.38	0.90	3.61	6.28	13.88	0.09	24.00
Current Ratio	0.50	0.39	0.48	0.47	1.65	1.76	3.20	0.12	1.38	0.90	3.61	6.28	13.88	0.09	24.00
Asset Turnover	0.19	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Interest Coverage	78.76	n/a	-303.25	-472.75	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Return on Equity	1.12	1.14	0.99	1.55	0.05	0.06	-2.59	-0.24	-0.11	n/a	n/a	n/a	n/a	n/a	-0.04
Return on Assets	-0.34	-0.65	-0.33	-0.2	-0.03	-0.04	-0.1	-0.03	-0.01	n/a	n/a	n/a	n/a	n/a	-0.04
Return on Invested Capital	6.57	2.32	15.41	-4.14	-0.05	-0.06	-0.11	-0.02	0.10	n/a	n/a	n/a	n/a	n/a	-0.04
Dividend Yield	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Payout Ratio	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit Margin	0.50	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Net Profit Margin	-1.82	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Profit Margin	-1.82	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Profit Margin	-1.8	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
FCF Margin	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
EBITDA Margin	-2.34	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a